相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anticonvulsant, Anxiolytic and Antidepressant Properties of the β-caryophyllene in Swiss Mice: Involvement of Benzodiazepine-GABAAergic, Serotonergic and Nitrergic Systems
George L. da Silva Oliveira et al.
CURRENT MOLECULAR PHARMACOLOGY (2021)
Antibody Prevalence in Epilepsy before Surgery (APES) in drug-resistant focal epilepsy
Yi Li et al.
EPILEPSIA (2021)
Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement
Dimitris Spyridakos et al.
NEUROCHEMISTRY INTERNATIONAL (2021)
A- and D-type potassium currents regulate axonal action potential repolarization in midbrain dopamine neurons
Yujie Xiao et al.
NEUROPHARMACOLOGY (2021)
Characterization of Subtype Selective Cannabinoid CB2 Receptor Agonists as Potential Anti-Inflammatory Agents
Yaliang Tang et al.
PHARMACEUTICALS (2021)
Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression
Eun-Sang Hwang et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
Proconvulsant effect of trans-cinnamaldehyde in pentylenetetrazole-induced kindling model of epilepsy: The role of TRPA1 channels
Caner Gunaydin et al.
NEUROSCIENCE LETTERS (2020)
Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials
Meir Bialer et al.
EPILEPSIA (2020)
Predictors of drug-resistance in epilepsy with auditory features
Lin Zhang et al.
EPILEPSY RESEARCH (2020)
Intrinsic network architecture predicts the effects elicited by intracranial electrical stimulation of the human brain
Kieran C. R. Fox et al.
NATURE HUMAN BEHAVIOUR (2020)
Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy
Lara Senn et al.
PHARMACEUTICALS (2020)
The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders
Qing Xin et al.
ACTA PHARMACOLOGICA SINICA (2020)
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Wolfgang Loescher et al.
PHARMACOLOGICAL REVIEWS (2020)
Cannabidiol inhibits febrile seizure by modulating AMPA receptor kinetics through its interaction with the N-terminal domain of GluA1/GluA2
Yongzhou Yu et al.
PHARMACOLOGICAL RESEARCH (2020)
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Heterogeneity of cannabinoid ligand-induced modulations in intracellular Ca2+ signals of mouse pancreatic acinar cells in vitro
Kun-kun Xia et al.
ACTA PHARMACOLOGICA SINICA (2019)
Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons
Ana Canseco-Alba et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Increased expression of cannabinoid CB2 and serotonin 5-HT1A heteroreceptor complexes in a model of newborn hypoxic-ischemic brain damage
Rafael Franco et al.
NEUROPHARMACOLOGY (2019)
Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy
Sebastian Guelfi et al.
BRAIN (2019)
Activation of ATP-sensitive K-channel promotes the anticonvulsant properties of cannabinoid receptor agonist through mitochondrial ATP level reduction
Arvin Haj-Mirzaian et al.
EPILEPSY & BEHAVIOR (2019)
The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson's Disease (PD) and Major Depressive Disorder (MDD)
Kai Yang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Mechanisms of cannabinoid CB2 receptor-mediated reduction of dopamine neuronal excitability in mouse ventral tegmental area
Zegang Ma et al.
EBIOMEDICINE (2019)
Microbiota-gut brain axis involvement in neuropsychiatric disorders
Luigi Francesco Iannone et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Neuroprotective effects of isoliquiritigenin against cognitive impairment via suppression of synaptic dysfunction, neuronal injury, and neuroinflammation in rats with kainic acid-induced seizures
Xiaobo Zhu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Annamaria Vezzani et al.
NATURE REVIEWS NEUROLOGY (2019)
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
Yen-Chen Anne Feng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Transcriptome analysis in patients with temporal lobe epilepsy
Christina Kjaer et al.
BRAIN (2019)
Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice
Lindsey Shapiro et al.
EPILEPSIA (2019)
Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow
Jie Wu
ACTA PHARMACOLOGICA SINICA (2019)
The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids
Keith A. Kwan Cheung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet (vol 173, pg 1728, 2018)
Christine A. Olson et al.
CELL (2018)
An overview of the cannabinoid type 2 receptor system and its therapeutic potential
Bihua Bie et al.
CURRENT OPINION IN ANESTHESIOLOGY (2018)
Metabolism of amino acid neurotransmitters: the synaptic disorder underlying inherited metabolic diseases
Stefan Koelker
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Epidemiological profile of epilepsy in low income populations
Camilo Espinosa-Jovel et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2018)
Epilepsy
Orrin Devinsky et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System
Patricia Schonhofen et al.
CNS DRUGS (2018)
Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder
Zhan Lim et al.
EPILEPSY RESEARCH (2018)
The central cannabinoid receptor type-2 (CB2) and chronic pain
Yuchao Shang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats
Megan N. Huizenga et al.
EPILEPSIA (2017)
Cannabinoid receptor 1/2 double-knockout mice develop epilepsy
Shane Rowley et al.
EPILEPSIA (2017)
Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy
Magdalena Szaflarski et al.
EPILEPSY & BEHAVIOR (2017)
The potential role of cannabinoids in epilepsy treatment
Carmen De Caro et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Cannabinoid CB1 and CB2 receptors differentially modulate L- and T-type Ca2+ channels in rat retinal ganglion cells
Wen-Jing Qian et al.
NEUROPHARMACOLOGY (2017)
DISTINCT ROLES OF NEURONAL AND MICROGLIAL CB2 CANNABINOID RECEPTORS IN THE MOUSE HIPPOCAMPUS
Yong Li et al.
NEUROSCIENCE (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
Joshua S. Kaplan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The potential role of cannabinoids in epilepsy treatment
Carmen De Caro et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
The Phosphodiesterase 10A Inhibitor PF-2545920 Enhances Hippocampal Excitability and Seizure Activity Involving the Upregulation of GluA1 and NR2A in Post-synaptic Densities
Yanke Zhang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano et al.
FRONTIERS IN NEUROSCIENCE (2017)
The PTZ kindling mouse model of epilepsy exhibits exploratory drive deficits and aberrant activity amongst VTA dopamine neurons in both familiar and novel space
Mahboubeh Ahmadi et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats
Cristiane R. de Carvalho et al.
EPILEPSY RESEARCH (2016)
Quantification of the Functional Expression of the Ca2+-Activated K+ Channel KCa3.1 on Microglia from Adult Human Neocortical Tissue
Linda V. Blomster et al.
GLIA (2016)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures
Yuki Sugaya et al.
CELL REPORTS (2016)
Potassium Channels in Epilepsy
Ruediger Koehling et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors
Iraj Aghaei et al.
EPILEPSY RESEARCH (2015)
Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol
Antonio Ortega-Alvaro et al.
ADDICTION BIOLOGY (2015)
Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy
Valerio Rizzo et al.
EPILEPSY RESEARCH (2014)
The interaction between ghrelin and cannabinoid systems in penicillin-induced epileptiform activity in rats
Gokhan Arslan et al.
NEUROPEPTIDES (2014)
Neuroactive peptides as putative mediators of antiepileptic ketogenic diets
Carmela Giordano et al.
FRONTIERS IN NEUROLOGY (2014)
Role of CB2 Cannabinoid Receptors in the Rewarding, Reinforcing, and Physical Effects of Nicotine
Francisco Navarrete et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Cannabinoid CB2 receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice
Francisco Navarrete et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors
Maria S. Garcia-Gutierrez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy
Martin J. Gunthorpe et al.
EPILEPSIA (2012)
Pilocarpine-induced temporal lobe epilepsy in the rat is associated with increased dopamine neuron activity
Pierangelo Cifelli et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Behavioral Effects of Pulp Exposure in Mice Lacking Cannabinoid Receptor 2
Natasha M. Flake et al.
JOURNAL OF ENDODONTICS (2012)
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
Emmanuel S. Onaivi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
The effect of co-administration of the NMDA blocker with agonist and antagonist of CB1-receptor on penicillin-induced epileptiform activity in rats
Duygu Cakil et al.
EPILEPSY RESEARCH (2011)
The role of central CB2 cannabinoid receptors on food intake in neonatal chicks
L. Emadi et al.
JOURNAL OF COMPARATIVE PHYSIOLOGY A-NEUROETHOLOGY SENSORY NEURAL AND BEHAVIORAL PHYSIOLOGY (2011)
Somatic Membrane Potential and Kv1 Channels Control Spike Repolarization in Cortical Axon Collaterals and Presynaptic Boutons
Amanda J. Foust et al.
JOURNAL OF NEUROSCIENCE (2011)
Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis
Jose L. Lanciego et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
Maria S. Garcia-Gutierrez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Therapeutic Potential of Cannabinoids in the Treatment of Neuroinflammation Associated with Parkinsons Disease
J. P. Little et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Zheng-Xiong Xi et al.
NATURE NEUROSCIENCE (2011)
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Antonio Ortega-Alvaro et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors
Bogna Ignatowska-Jankowska et al.
NEUROSCIENCE LETTERS (2011)
The Highs and Lows of Cannabinoid Receptor Expression in Disease: Mechanisms and Their Therapeutic Implications
Lydia K. Miller et al.
PHARMACOLOGICAL REVIEWS (2011)
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
J. Agudo et al.
DIABETOLOGIA (2010)
Cannabinoid and Cannabinoid-Like Receptors in Microglia, Astrocytes, and Astrocytomas
Nephi Stella
GLIA (2010)
The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats
Ramazan Kozan et al.
EPILEPSIA (2009)
Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands
Q. -R. Liu et al.
GENES BRAIN AND BEHAVIOR (2009)
Identification of Transcription Start Sites and Preferential Expression of Select CB2 Transcripts in Mouse and Human B Lymphocytes
Tracy A. Sherwood et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway
Maria Teresa Viscomi et al.
JOURNAL OF NEUROSCIENCE (2009)
Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression
Emmanuel S. Onaivi et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy
Laxmikant S. Deshpande et al.
NEUROSCIENCE LETTERS (2007)
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance
GA Cabral et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy
MJ Wallace et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission
SB Floresco et al.
NATURE NEUROSCIENCE (2003)
Presynaptic specificity of endocannabinoid signaling in the hippocampus
RI Wilson et al.
NEURON (2001)
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
RI Wilson et al.
NATURE (2001)
Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells
AC Kreitzer et al.
NEURON (2001)
Expression of CB2 cannabinoid receptor mRNA in adult rat retina
QJ Lu et al.
VISUAL NEUROSCIENCE (2000)
分享论文
